Efavirenz contains not less than 98.0% and not more than 102.0% of C14H9ClF3NO2, calculated on the anhydrous, solvent-free basis.

申請商
漢旭股份有限公司 
適應症
抗病毒藥物,用於人體免疫缺乏病毒第一型感染。
含量
0